Drug lookup | Fillwise

GABAPENTIN

All products: general benefit

Other products in the same Health Canada class (N02BF) — coverage varies; not interchangeable

Pregabalin (Lyrica): general benefit, Not a benefit

Neurontin · DIN 02084279 · 300mg · capsule

General benefitMarketed · checked 2026-09-20

StatusGeneral benefit

Write on scriptno code needed

Patient paysPatient pays: program not supplied; amount cannot be determined.

Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.

1 brand, same coverage

Neurontin · DIN 02084279 Manufacturer: Upjohn Canada ULC; listing date 1996-10-01 Health Canada: Marketed since 2023-05-05 · brand NEURONTIN · ATC N02BF01 GABAPENTIN · form Capsule · route Oral · ingredients GABAPENTIN 300 MG · company Bgp pharma ulc · schedule Prescription

Check this DIN again · Health Canada product record

Ministry pays: $0.1012 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15945 · Verify on the e-Formulary ↗ (DIN 02084279)

Source record

DIN 02084279: Neurontin Raw flags: sec3=Y Item: 281200063; group id 430; item number 1071; lccId None; manufacturer id UJC Source form: Cap; strength: 300mg Recorded listing: General benefit Source prices (unrounded): $1.3430; ministry $0.1012 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02084279 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15945

Interchangeable products

AG-Gabapentin · DIN 02477920 · $0.1012 Apo-Gabapentin · DIN 02244305 · $0.1012 Auro-Gabapentin · DIN 02321211 · $0.1012 Co Gabapentin · DIN 02256150 · $0.1012 Gabapentin · DIN 02246315 · $0.1012 Gabapentin · DIN 02353253 · $0.1012 Gabapentin Capsules USP · DIN 02416859 · $0.1012 Jamp Gabapentin Capsules · DIN 02535254 · $0.1012 Jamp-Gabapentin · DIN 02361485 · $0.1012 Mar-Gabapentin · DIN 02391481 · $0.1012 Mint-Gabapentin · DIN 02408899 · $0.1012 NRA-Gabapentin · DIN 02550024 · $0.1012 PMS-Gabapentin · DIN 02243447 · $0.1012 Ran-Gabapentin · DIN 02319063 · $0.1012 Teva-Gabapentin · DIN 02244514 · $0.1012

Shortage status: not checked (no credentials)

Other drugs in the same formulary class (28:12 Anticonvulsants) and how they are covered

Matched class: 28:12 Anticonvulsants

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: CLONAZEPAM, DIVALPROEX SODIUM, ETHOSUXIMIDE, LAMOTRIGINE, VALPROATE SODIUM Some products covered without a code (check the product listing): CARBAMAZEPINE, PHENYTOIN (DIPHENYLHYDANTOIN), PHENYTOIN (DIPHENYLHYDANTOIN) SODIUM, PREGABALIN, PRIMIDONE, TOPIRAMATE, VALPROIC ACID 28:12 Anticonvulsants

PREGABALIN

· 102 products · General benefit (93), Off-Formulary Interchangeable, not an ODB benefit (9) · strengths: 25mg, 50mg, 75mg, 150mg, 225mg, 300mg · Cap

CARBAMAZEPINE

· 15 products · Listed, not a benefit (3), General benefit (6), Temporary benefit (2), Limited Use, codes 67 (4) · strengths: 100mg, 200mg, 400mg, 100mg/5mL · Chew Tab, ER Tab, LA Tab, Oral Susp, Tab

CLONAZEPAM

· 9 products · General benefit · strengths: 0.5mg, 2mg · Tab

DIVALPROEX SODIUM

· 9 products · General benefit · strengths: 125mg, 250mg, 500mg · Ent Tab

ETHOSUXIMIDE

· 4 products · General benefit · strengths: 250mg, 50mg/mL · Cap, O/L

LAMOTRIGINE

· 28 products · General benefit · strengths: 25mg, 100mg, 150mg · Tab

PHENYTOIN (DIPHENYLHYDANTOIN)

· 4 products · General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (2), General benefit (2) · strengths: 6mg/mL, 25mg/mL, 50mg · O/L, Tab

PHENYTOIN (DIPHENYLHYDANTOIN) SODIUM

· 4 products · General benefit (3), Limited Use, codes 481, 657 (1) · strengths: 30mg, 100mg, 50mg/mL · Cap, Inj Sol (Preservative Free)

PRIMIDONE

· 4 products · General benefit (2), Listed, not a benefit (2) · strengths: 125mg, 250mg · Tab

TOPIRAMATE

· 54 products · Limited Use, codes 321 (2), Off-Formulary Interchangeable, not an ODB benefit (3), General benefit (49) · strengths: 15mg, 25mg, 50mg, 100mg, 200mg · Sprinkle Cap, Tab

VALPROATE SODIUM

· 5 products · General benefit · strengths: 50mg/mL · O/L

VALPROIC ACID

· 5 products · Listed, not a benefit (2), General benefit (3) · strengths: 250mg, 500mg · Cap, Ent Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 28:12 and 11 more

Full class listing Related classes: 28:08 Analgesics, 28:10 Opiate Antagonists, 28:16 Psychotherapeutic Agents, 28:20 C.N.S. Stimulants, 28:24 Sedatives and Hypnotics, 28:36 Antiparkinsonian Agents, 28:92 Miscellaneous Central Nervous System Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.

What the Health Canada label says it is for

1 INDICATIONS Adults NEURONTIN (gabapentin) is indicated as adjunctive therapy for the management of patients with epilepsy who are not satisfactorily controlled with conventional therapy. 1.1 Pediatrics Pediatrics (< 18 years of age): Based on the data submitted and reviewed by Health Canada, the safety and efficacy of NEURONTIN in pediatric patients has not been established; therefore, Health Canada has not authorized an indication for pediatric use. (See 7.1.3 Pediatrics). 1.2 Geriatrics Geriatrics (> 65 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for geriatric use. (See 7.1.4 Geriatrics). https://pdf.hres.ca/dpd_pm/00080598.PDF PM date: MAY 22, 2025 Source product: NEURONTIN; DIN 02084260; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.